|
|
Volumn 12, Issue 8, 2001, Pages 1057-1058
|
|
ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP)
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA FETOPROTEIN;
ANTINEOPLASTIC AGENT;
CHORIONIC GONADOTROPIN BETA SUBUNIT;
HORMONE DERIVATIVE;
PLATINUM DERIVATIVE;
PROSTATE SPECIFIC ANTIGEN;
ADULT;
ARTICLE;
CANCER;
CANCER CLASSIFICATION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER INCIDENCE;
CANCER PALLIATIVE THERAPY;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER RISK;
CLINICAL PROTOCOL;
CONTROLLED STUDY;
EUROPEAN UNION;
FEMALE;
FOLLOW UP;
HEALTH CARE ORGANIZATION;
HORMONAL THERAPY;
HUMAN;
HUMAN TISSUE;
IDIOPATHIC DISEASE;
IMMUNOHISTOCHEMISTRY;
LYMPH NODE METASTASIS;
MALE;
MEDICAL ASSESSMENT;
PATIENT CARE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
TREATMENT PLANNING;
TUMOR DIFFERENTIATION;
EUROPE;
HUMANS;
NEOPLASM STAGING;
NEOPLASMS, UNKNOWN PRIMARY;
RISK ASSESSMENT;
SEX FACTORS;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 0034830208
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1017409423484 Document Type: Article |
|
Times cited : (15)
|
|
References (4)
|
